Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VASOSHOCK: Early Noradrenaline vs Fluid in ED Hypotension
NCT05931601Phase 3Recruiting
- Sponsor
- University Hospital Odense
- Start
- Dec 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of norepinephrine in hypotension, Shock, sponsored by University Hospital Odense. Started Dec 2023; status: recruiting.
02
Drugs
norepinephrine
03
Conditions
hypotensionShock
Beyond the preview
Go deeper on NCT05931601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05931601.